Lilly and Cipla tie up to broaden access of weight-loss therapy | India News – The Times of India
Eli Lilly and Cipla announced an agreement to distribute and promote tirzepatide in India under a second brand name, Yurpeak. This strategic agreement aims to expand the availability of tirzepatide by enabling broader access across the country beyond cities where Lilly already has an established presence. In March, Lilly launched its blockbuster weight-loss therapy, tirzepatide…